Posts

Showing posts with the label tenecteplase fda approval stroke

Evolving Standards of Care: Revisiting the Treatment Window in Acute Ischemic Stroke

Image
What is Ischemic Stroke? Ischemic stroke is a devastating condition caused by a blockage in a blood vessel supplying blood to the brain. It is the most common type of stroke, accounting for over 80% of cases. Timely and effective treatment is critical to prevent disability and death. In this microblog, we will discuss the latest developments and future prospects in the acute ischemic stroke treatment landscape. Shortcomings of the Current Acute Ischemic Stroke Treatment Landscape Alteplase intravenous thrombolysis and mechanical thrombectomy are currently available treatments for acute ischemic stroke . Some treatments do have drawbacks, though, such as a constrained therapeutic window and patient populations for which they are contraindicated. Moreover, some patients do not respond to conventional medications, emphasizing the requirement for alternate therapies. Early Detection Crucial for Acute Ischemic Stroke Treatment Ischemic stroke symptoms might be mild and may not be immedia...